U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX4141987: GSM3165351: Ribo_wt_polysome2; Mus musculus; OTHER
1 ILLUMINA (Illumina HiSeq 4000) run: 21M spots, 1.7G bases, 767Mb downloads

Submitted by: NCBI (GEO)
Study: RNA m6A-Ythdf1 in dendritic cells triggers anti-tumor immunity (ribo-seq and m6a-seq in GMDCs)
show Abstracthide Abstract
Emerging evidence emphasizes the important role of tumor neoantigen in generating the spontaneous antitumor immune response and predicting the clinical response to immunotherapies. Despite the presence of numerous neoantigens, complete tumor elimination rarely occurs in majority of patients due to failures in mounting a sufficient and lasting antitumor immunity. Here we show that the durable neoanitgen-specific immunity is regulated by a m6A-binding protein, Ythdf1. In contrast to wild-type mice, Ythdf1-deficient (Ythdf1-/-) mice generate more antigen-specific CD8+ T cell response for persistent tumor control. Loss of Ythdf1 in dendritic cell (DC) results in an enhanced cross-presentation of tumor antigen and cross-priming of CD8+ T cell in vivo. To confirm our observations, we performed Ribo-Seq to analyze the translational efficiency of genes in DCs and performed m6A-seq to locate the m6A sites. Overall design: BMDCs obtained from WT and YTHDF1 KO mice were used to genetarate ribo-seq (monosome footprints and polysome footprints) and m6a-seq libraries. Two replicates for each conditions.
Sample: Ribo_wt_polysome2
SAMN09283389 • SRS3355797 • All experiments • All runs
Organism: Mus musculus
Library:
Instrument: Illumina HiSeq 4000
Strategy: OTHER
Source: TRANSCRIPTOMIC
Selection: other
Layout: SINGLE
Construction protocol: For Ribo-Seq:5x10e6 DCs were treated with 100 μg/ml cycloheximide (CHX) for 7 min. The cells were then harvested by the cell lifter. The cell suspension was spun at 400g for 5 min and the cell pellet was washed twice with 5 ml cold PBS with CHX (100 μg/ml). 200 μl lysis buffer (10 mM Tris, pH 7.4, 150 mM KCl, 5 mM MgCl2, 100 μg/ml CHX, 0.5% Triton-X-100, freshly add 1:100 protease inhibitor, 40 U/ml SUPERasin) was added to the cell pellet and lysed on ice for 15 min with rotating; For m6A-Seq: Total RNA was isolated from DCs. Polyadenylated RNA was further enriched from total RNA by using Dynabeads® mRNA Purification Kit (Invitrogen). For Ribo-Seq:10% clarified lysate was saved as INPUT and the rest lysate was separated through a 5ml 10%-50% sucrose gradient and centrifuged at 4°C for 2 h at 28,000 r.p.m. Fractions were collected separately and analyzed by Qubit™ RNA HS Assay Kit (Invitrogen). The fractions corresponding to ribosomes were combined and concentrated on Amicon-Ultra 100K columns (Millipore). 2 A260 units of ribosome fractions were digested with 60U RNase I (Ambion) at room temperature for 30 min. RNA was extracted by RNA Clean&Concentrate (Zymo) and ribosomal RNA were deleted prior to size selection. RNA fragments (26-32nt) were isolated by 15% denaturing Urea-PAGE gel. RNA was eluted from gel in elution buffer (300 mM sodium acetate pH 5.2, 1 mM EDTA) followed by phenol-chloroform extract and ethanol precipitation. RNA fragments were dephosphorylated and prepared into libraries by SMARTer® smRNA-Seq Kit (Clontech); For m6A-Seq: RNA samples were fragmented into ~100-nucleotide-long fragments with sonication. Fragmented RNA (100ng mRNA or 5µg total RNA) was performed m6A-IP following EpiMark N6-methyladenosine enrichment kit (NEB E1610S) protocol. RNA was enriched through RNA Clean&Concentration-5 (Zymo Research) and used for library generation with SMARTer Stranded Total RNA-Seq Kit (Takara).
Experiment attributes:
GEO Accession: GSM3165351
Links:
Runs: 1 run, 21M spots, 1.7G bases, 767Mb
Run# of Spots# of BasesSizePublished
SRR723565220,963,5081.7G767Mb2019-01-01

ID:
5628255

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...